Coronamonomania Thrives in Darkness, Part 77

Yeah, the lockdowns and more importantly, the terror campaign, were just  great, no adverse effects at all, like people missing needed hospitalizations and as a result, dying.  This study from Denmark found that hospitalizations for non-CV-19 conditions dropped by over a fourth during the epidemic, and that much of the decrease came from serious diagnostic categories.  In addition, mortality from these non-CV-19 causes rose.  That is on the politicians and public health experts who pushed the terror and the lockdowns.  (BMJ Article)

Okay, for those who want to buy into the claim that CV-19, or the mRNA vaccines, can someone get into our DNA and who rely on the study from last fall claiming to have observed, in a manipulated lab setting, how this could happen; recall that I warned at the time that without replication, such a fantastical claim was inherently unbelievable.  And here is a study which finds absolutely no evidence to support that claim that the virus or vaccine sequences could somehow be integrated into a cell’s DNA.  (Medrxiv Paper)   Several months, no replication and a study rejecting the finding equals it wasn’t true.

I am still fascinated by the role of prior seasonal coronavirus infections in limiting CV-19 infection or seriousness of disease.  This is another study on the topic.  (Medrxiv Paper)    The authors looked at data from the UK to conclude that seasonal coronavirus infection adaptive immunity had an average duration of over 7 years and that prior infection, which peaks in children, might partly explain the age distribution of CV-19 cases.

These researchers studied whether CV-19 vaccinations helped protect against other coronavirus varieties.  (Medrxiv Paper)   The researchers found in humans that CV-19 vaccination protected against seasonal coronavirus and the original SARS virus.  Using mice, they also found that SARS vaccines protected against CV-19 and that prior infection with seasonal coronaviruses delivered some protection against CV-19.  The route of protection was both antibody and T cell based.

So in a hospital or LTC facility with CV-19 patients you might expect some virus floating around, but how much and is it viable, i.e., capable of replication.  This paper put air samplers in patients’ rooms, at a distance of 6 feet from the patient (does that 6 feet sound familiar) and did find virus by PCR testing, but gee, it was all in low volumes and none of it cultured, or showed replication.  The cycle numbers ranged from 30 to 38.  This helps explains so many low positives from various settings.  Fragments may be out there floating around, and they may be picked up by PCR testing but it isn’t viable virus and people aren’t infected.  PCR testing really is close to useless.  (Medrxiv Paper)

One reason there isn’t much outdoor transmission is that ultraviolet light disables CV-19 quite quickly.  This paper explores that phenomenon.  (Medrxiv Paper)

The title of this paper is scarier than the actual findings.  The authors examined the extent to which infection or vaccination provided protection against common variants.  They looked only at antibodies, not T cells.  They found some diminution of antibody response, but it was still there.  (Medrxiv Paper)